Thanks Raytser, A debacle on how to handle investor relations - surely the conf call should have been done before relisting after the rasing? It seems beyond belief that a professional company with paid Investor Relations team can cock this up.
What was concerning on the conf call is that in all reality - pathology is break even. If the sword has not been put through the support area then there is no excuse - 80 people in HR - what a joke.
The question is whether at 1.20 it it is a good base for a 2025 position. Assuming some contract awards will be announced to shore up the price (as per the conf call) then you would expect so. However, the fact that it plunged through the TERP of $1.70 doesnt bode well.
I think I will look at taking a position low 1.20's and wait
Ann: Notice of conference call, page-5
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.045(3.17%) |
Mkt cap ! $1.063B | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.48 | $1.41 | $1.872M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6277 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 17540 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| HLS (ASX) Chart |